Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria De Santis

Showing results (61-70 of 278) with videos related to

Pageof 28
Sort By:
Autoimmunity Reviews|January 21, 2021
The biology, pathogenetic role, clinical implications, and open issues of serum anti-neutrophil cytoplasmic antibodiesGiacomo Ramponi, Marco Folci, Maria De Santis, et al.
Current Opinion in Urology|September 16, 2015
Immunotherapies for bladder cancer: a new hopeFarhad Fakhrejahani, Yusuke Tomita, Agnes Maj-Hes, et al.
Current Opinion in Immunology|May 24, 2025
Mechanistic considerations linking SARS-CoV-2 infection, inflammation, and the loss of immune toleranceAntonio Tonutti, Francesca Motta, Natasa Isailovic, et al.
Journal of Translational Autoimmunity|January 10, 2022
Non-adherence and discontinuation rate for oral and parenteral methotrexate: A retrospective-cohort study in 8,952 patients with psoriatic arthritisElena Generali, Greta Carrara, Alessandra Bortoluzzi, et al.
Frontiers in Immunology|March 17, 2022
Antigen Reactivity and Clinical Significance of Autoantibodies Directed Against the Pyruvate Dehydrogenase Antigen Complex in Patients With Connective Tissue DiseaseAngela Ceribelli, Natasa Isailovic, Carolina Gorlino, et al.
Future Oncology (London, England)|January 10, 2025
Treatment of metastatic urothelial carcinoma in the United Kingdom, France, Germany, Italy, and SpainAhmet Hasaligil, Vicki Munro, Torsten Strunz-McKendry, et al.
Frontiers in Immunology|September 27, 2023
Proteomic aptamer analysis reveals serum biomarkers associated with disease mechanisms and phenotypes of systemic sclerosisFrancesca Motta, Antonio Tonutti, Natasa Isailovic, et al.
International Journal of Molecular Sciences|September 27, 2025
Detection and Clinical Associations of Autoantibodies to Heterogeneous Nuclear Ribonucleoprotein (hnRNP) A2/B1 in Patients with Systemic SclerosisAntonio Tonutti, Natasa Isailovic, Lukas Frischknecht, et al.
Arthritis Research & Therapy|March 27, 2010
B cell depletion in diffuse progressive systemic sclerosis: safety, skin score modification and IL-6 modulation in an up to thirty-six months follow-up open-label trialSilvia Bosello, Maria De Santis, Gina Lama, et al.
Cancer Investigation|July 31, 2008
Cell cycle dysregulation influences survival in high risk breast cancer patientsRobert Königsberg, Olga Rögelsperger, Walter Jäger, et al.
Pageof 28

Showing results (61-70 of 278) with videos related to

Sort By:
Pageof 28
Autoimmunity Reviews|January 21, 2021
The biology, pathogenetic role, clinical implications, and open issues of serum anti-neutrophil cytoplasmic antibodiesGiacomo Ramponi, Marco Folci, Maria De Santis, et al.
Current Opinion in Urology|September 16, 2015
Immunotherapies for bladder cancer: a new hopeFarhad Fakhrejahani, Yusuke Tomita, Agnes Maj-Hes, et al.
Current Opinion in Immunology|May 24, 2025
Mechanistic considerations linking SARS-CoV-2 infection, inflammation, and the loss of immune toleranceAntonio Tonutti, Francesca Motta, Natasa Isailovic, et al.
Journal of Translational Autoimmunity|January 10, 2022
Non-adherence and discontinuation rate for oral and parenteral methotrexate: A retrospective-cohort study in 8,952 patients with psoriatic arthritisElena Generali, Greta Carrara, Alessandra Bortoluzzi, et al.
Frontiers in Immunology|March 17, 2022
Antigen Reactivity and Clinical Significance of Autoantibodies Directed Against the Pyruvate Dehydrogenase Antigen Complex in Patients With Connective Tissue DiseaseAngela Ceribelli, Natasa Isailovic, Carolina Gorlino, et al.
Future Oncology (London, England)|January 10, 2025
Treatment of metastatic urothelial carcinoma in the United Kingdom, France, Germany, Italy, and SpainAhmet Hasaligil, Vicki Munro, Torsten Strunz-McKendry, et al.
Frontiers in Immunology|September 27, 2023
Proteomic aptamer analysis reveals serum biomarkers associated with disease mechanisms and phenotypes of systemic sclerosisFrancesca Motta, Antonio Tonutti, Natasa Isailovic, et al.
International Journal of Molecular Sciences|September 27, 2025
Detection and Clinical Associations of Autoantibodies to Heterogeneous Nuclear Ribonucleoprotein (hnRNP) A2/B1 in Patients with Systemic SclerosisAntonio Tonutti, Natasa Isailovic, Lukas Frischknecht, et al.
Arthritis Research & Therapy|March 27, 2010
B cell depletion in diffuse progressive systemic sclerosis: safety, skin score modification and IL-6 modulation in an up to thirty-six months follow-up open-label trialSilvia Bosello, Maria De Santis, Gina Lama, et al.
Cancer Investigation|July 31, 2008
Cell cycle dysregulation influences survival in high risk breast cancer patientsRobert Königsberg, Olga Rögelsperger, Walter Jäger, et al.
Pageof 28